• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

Second Course

Efalizumab retreatment works as effectively as original treatmentPhysician: Kim A. Papp, M.D.

Related Videos
3 experts are featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS
November 26th 2024

Jeff Stark, MD: Insights on the Approval of Bimekizumab for HS

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Maximizing the 2-Fold Benefits of Your Charitable Donations
November 26th 2024

Maximizing the 2-Fold Benefits of Your Charitable Donations

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Baricitinib Shows Superior Efficacy Versus Traditional Alopecia Treatments
November 25th 2024

Baricitinib Shows Superior Efficacy Versus Traditional Alopecia Treatments

New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma
November 25th 2024

New Algorithm Proposes Targeted Lipase Monitoring for Pancreatic Adverse Events In Melanoma

© 2024 MJH Life Sciences

All rights reserved.